Misha Beltran
@mishabeltran.bsky.social
Reposted by Misha Beltran
In Memory of Dr Felix Feng, our beloved friend and a giant in prostate cancer @ericsmall.bsky.social @ucsfcancer.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
In Memory of Dr. Felix Feng
www.sciencedirect.com
January 7, 2025 at 11:33 PM
In Memory of Dr Felix Feng, our beloved friend and a giant in prostate cancer @ericsmall.bsky.social @ucsfcancer.bsky.social
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Misha Beltran
I'm pleased to announce that the ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed and will fund a young prostate cancer investigator every year, in perpetuity. The First Felix Feng YIA recipient will be announced this spring and celebrated at ASCO's annual meeting.
December 19, 2024 at 12:16 AM
I'm pleased to announce that the ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed and will fund a young prostate cancer investigator every year, in perpetuity. The First Felix Feng YIA recipient will be announced this spring and celebrated at ASCO's annual meeting.
Reposted by Misha Beltran
SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals.
Free registration and Hybrid option!
In partnership with Servier and Medscape
Free registration and Hybrid option!
In partnership with Servier and Medscape
December 16, 2024 at 1:40 PM
SAVE THE DATE: The 4th Transatlantic Exchange in Oncology between @danafarber.bsky.social and Gustave Roussy will take place in Paris on Wednesday March 19, 2025 and will focus on Radiopharmaceuticals.
Free registration and Hybrid option!
In partnership with Servier and Medscape
Free registration and Hybrid option!
In partnership with Servier and Medscape
Reposted by Misha Beltran
Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine #ProstateCancer, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and @mishabeltran.bsky.social
aacrjournals.org/clincancerre...
aacrjournals.org/clincancerre...
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies
Abstract. Lineage plasticity and histologic transformation from prostate adenocarcinoma to neuroendocrine prostate cancer (NEPC) occurs in up to 15-20% of patients with castration-resistant prostate c...
aacrjournals.org
November 28, 2024 at 3:16 PM
Just in time for Thanksgiving, nice pathology framework for characterizing treatment emergent neuroendocrine #ProstateCancer, a biologically diverse entity that everyone has a hard time describing, in CCR - thanks to Michael Haffner and @mishabeltran.bsky.social
aacrjournals.org/clincancerre...
aacrjournals.org/clincancerre...